Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prostatic Neoplasms × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 311 Leukemia 140 Precursor Cell Lymphoblastic Leukemia-Lymphoma 137 Lymphoma 91 Myelodysplastic Syndromes 64 Lymphoma, Non-Hodgkin 55 Burkitt Lymphoma 50 Lymphoma, Mantle-Cell 48 Recurrence 47 Lymphoma, Large B-Cell, Diffuse 47 Congenital Abnormalities 38 Leukemia, Monocytic, Acute 33 Hodgkin Disease 32 Lymphoma, Follicular 31 Leukemia, Myelomonocytic, Acute 29 Leukemia, Erythroblastic, Acute 29 Leukemia, Megakaryoblastic, Acute 27 Leukemia, Myelomonocytic, Chronic 25 Lymphoma, Large-Cell, Immunoblastic 24 Leukemia, Biphenotypic, Acute 24 Leukemia, Lymphocytic, Chronic, B-Cell 23 Blast Crisis 23 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18 Myeloproliferative Disorders 17 Anemia, Refractory, with Excess of Blasts 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, B-Cell, Marginal Zone 16 Neoplasm, Residual 13 Leukemia, Myeloid, Chronic-Phase 13 Leukemia, Myeloid, Accelerated Phase 13

Interventions

Docetaxel 147 Magnetic Resonance Spectroscopy 122 Radiotherapy 121 Leuprolide 97 Prednisone 94 enzalutamide 90 Radiosurgery 89 Abiraterone Acetate 78 Androgen Antagonists 77 Goserelin 71 bicalutamide 68 gallium 68 PSMA-11 56 Specimen Handling 53 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 50 Surveys and Questionnaires 50 apalutamide 48 Radiation 42 Biopsy 42 Brachytherapy 39 Gonadotropin-Releasing Hormone 38 Standard of Care 37 abiraterone 35 Blood Specimen Collection 34 darolutamide 33 cabazitaxel 33 Radiotherapy, Intensity-Modulated 32 Exercise 32 Carboplatin 31 Triptorelin Pamoate 28 Pluvicto 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00480090 2019-02-15

SLAP

University Health Network, Toronto

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡